Investor Relations –

Financial &
Stock Information

Overview Financial Information

Nasdaq: SNSE –

Stock quote and chart.

Open
Previous Close
Day Range –
52-Week Range –
Volume
Market Cap
Shares Outstanding

Minimum 15 minutes delayed. Source: LSEG

Minimum 15 minutes delayed. Source: LSEG

Coverage –

Analyst coverage.

The following analysts have published research coverage on Faeth Therapeutics. Inclusion does not constitute endorsement by the company. Ratings and price targets reflect the views of the individual analyst.

Firm Analyst Email Phone Type Rating
BTIG, LLC
Jeet Mukherjee, Ph.D.
Cantor Fitzgerald & Co.
 Li Watsek | Eric Schmidt
Citi Research
 Geoff Meacham, Ph.D.
Leerink Partners LLC
 Andrew Berens, M.D.
Lucid Capital Markets
 Christopher Liu

Faeth Therapeutics, Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Faeth Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Faeth Therapeutics, Inc. or its management. Faeth Therapeutics, Inc. does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Delayed quote. All SEC filings are available on the SEC's EDGAR system at www.sec.gov. Documents presented here are for convenience only. The SEC filing is the authoritative source.

The drug product candidates described on this website are investigational agents that have not been approved by the Food and Drug Administration or any other regulatory authority. Their safety and efficacy have not been established.